HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macrophage-derived MMP-8 determines smooth muscle cell differentiation from adventitia stem/progenitor cells and promotes neointima hyperplasia.

AbstractAIMS:
Emerging evidence has suggested that adventitia stem/progenitor cells (AdSPCs) migrate into the intima of arteries in response to injury, where they differentiate towards smooth muscle cells (SMCs) and participate in neointimal hyperplasia. We have previously identified matrix metalloproteinase-8 (MMP8) as a key player in atherogenesis. In this study, we aimed to investigate the functional roles of macrophage-derived MMP8 in AdSPC differentiation and injury-induced arterial remodelling.
METHODS AND RESULTS:
We first observed an important role for MMP8 in SMC differentiation from embryonic stem cells, but this effect was not seen in AdSPCs. Instead, through macrophages/AdSPCs co-culture and macrophage conditional culture medium studies, we have demonstrated that the MMP8 protein secreted from macrophages promotes SMC differentiation from AdSPCs. Mechanistically, we showed that macrophage-derived MMP8 promotes SMC differentiation from AdSPCs through modulating transforming growth factor-β activity and a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)/Notch1 signalling. We further demonstrated that the binding site for CBF1, Suppressor of Hairless, and Lag-1 (CSL) within SMC gene promoters is responsible for Notch1 mediated SMC differentiation. Finally, we demonstrated that macrophage-derived MMP8 increased injury-induced neointimal SMC hyperplasia by activating ADAM10/Notch1 signalling.
CONCLUSIONS:
We have identified macrophage-derived MMP8 as a regulator in SMC differentiation from AdSPCs and neointimal SMC hyperplasia in response to injury. Our data provide new insights into the roles of MMP8 in AdSPC differentiation and the pathogenesis of neointima formation in the context of angiographic restenosis, and therefore may aid in the development of novel therapeutic agents for the prevention of this disease.
AuthorsFeng Yang, Qishan Chen, Mei Yang, Eithne Margaret Maguire, Xiaotian Yu, Shiping He, Rui Xiao, Claire S Wang, Weiwei An, Wei Wu, Yijiang Zhou, Qingzhong Xiao, Li Zhang
JournalCardiovascular research (Cardiovasc Res) Vol. 116 Issue 1 Pg. 211-225 (01 01 2020) ISSN: 1755-3245 [Electronic] England
PMID30778537 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightPublished on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: [email protected].
Chemical References
  • Immunoglobulin J Recombination Signal Sequence-Binding Protein
  • Membrane Proteins
  • Notch1 protein, mouse
  • Rbpj protein, mouse
  • Receptor, Notch1
  • Amyloid Precursor Protein Secretases
  • MMP8 protein, mouse
  • Matrix Metalloproteinase 8
  • ADAM10 Protein
  • Adam10 protein, mouse
Topics
  • ADAM10 Protein (genetics, metabolism)
  • Adventitia (enzymology, pathology)
  • Amyloid Precursor Protein Secretases (genetics, metabolism)
  • Animals
  • Carotid Artery Injuries (enzymology, genetics, pathology)
  • Cell Differentiation
  • Cell Proliferation
  • Cells, Cultured
  • Coculture Techniques
  • Disease Models, Animal
  • Immunoglobulin J Recombination Signal Sequence-Binding Protein (genetics, metabolism)
  • Macrophages (enzymology, pathology)
  • Matrix Metalloproteinase 8 (deficiency, genetics, metabolism)
  • Membrane Proteins (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout, ApoE
  • Muscle, Smooth, Vascular (enzymology, pathology)
  • Myocytes, Smooth Muscle (enzymology, pathology)
  • Neointima
  • Paracrine Communication
  • Receptor, Notch1 (genetics, metabolism)
  • Signal Transduction
  • Stem Cells (enzymology, pathology)
  • Vascular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: